ImmunologybioRxiv
Utilizing a PTPN22 gene signature to predict response to targeted therapies in rheumatoid arthritis
H.-H. Chang, C.-H. Ho, B. Tomita…·I.-C. Ho
The paper identifies a PTPN22 gene signature in RA patients that can be reversed by targeted therapies and correlates with clinical response.
DOI 10.1016/j.jaut.2019.04.012